High Eye Pressure

Ocular Hypertension: What It Means When Your Eye Pressure Is High

Being told that your eye pressure is elevated can be alarming — especially if your doctor mentioned the word glaucoma in the same conversation. Understanding what ocular hypertension is, how it differs from glaucoma, and what it means for your long-term eye health is an important first step in managing your care with clarity rather than anxiety.

What Is Ocular Hypertension?

Ocular hypertension refers to intraocular pressure (IOP) that is higher than the statistically normal range — generally defined as greater than 21 mmHg — in the absence of any detectable optic nerve damage or visual field loss. In other words, the pressure is elevated, but the eye shows no signs of glaucoma damage at the time of evaluation.

Normal intraocular pressure ranges from approximately 10 to 21 mmHg in most individuals, though this range is a statistical average rather than an absolute threshold. The eye maintains this pressure through a continuous cycle of fluid (aqueous humor) production and drainage. When the drainage system becomes less efficient, pressure builds — and sustained elevated pressure can, over time, damage the optic nerve.

Ocular Hypertension Is Not the Same as Glaucoma

This is the most important distinction: ocular hypertension is a risk factor for glaucoma, not glaucoma itself. Glaucoma is defined by the presence of characteristic optic nerve damage, with or without visual field loss — not by pressure elevation alone. Many patients with elevated IOP never develop glaucoma, and a meaningful proportion of glaucoma patients actually have IOP within the normal range (a condition called normal-tension glaucoma).

Whether a patient with ocular hypertension will develop glaucoma depends on a combination of factors, including the degree of pressure elevation, corneal thickness (thicker corneas can make pressure measurements appear artificially high), the appearance of the optic nerve, family history of glaucoma, age, race, and the results of visual field testing.

The Ocular Hypertension Treatment Study

The landmark Ocular Hypertension Treatment Study (OHTS) — a large, rigorous clinical trial — established that treating elevated IOP with pressure-lowering eye drops reduces the risk of developing glaucoma in patients with ocular hypertension. However, the same study showed that the majority of untreated patients with ocular hypertension did not develop glaucoma over a five-year period, underscoring that not every patient with elevated pressure requires immediate treatment. The decision is individualized based on the patient’s overall risk profile.

Monitoring and Management at River City Eye Associates

At River City Eye Associates, Dr. Aaron Hager evaluates patients with ocular hypertension through comprehensive examination including IOP measurement, corneal thickness assessment (pachymetry), detailed optic nerve evaluation with OCT imaging, and visual field testing. Together, these measurements allow a precise assessment of the patient’s individual glaucoma risk and guide a decision about whether observation alone or pressure-lowering treatment is most appropriate.

Patients who are monitored without treatment are followed at regular intervals — typically every six to twelve months — with repeat IOP measurements and optic nerve imaging to detect any early signs of change. Patients for whom treatment is recommended most commonly start with once-daily pressure-lowering eye drops, which are highly effective and well tolerated by most patients. Laser treatment (SLT) is also an excellent first-line option for some patients.

If you have been told your eye pressure is elevated, or if you have a family history of glaucoma and have not had a comprehensive eye exam, call River City Eye Associates at 210-930-2015 to schedule an evaluation in San Antonio.